Research Studies

Non-Proliferative Diabetic Retinopathy Study. Now Enrolling.

Now Enrolling

This is a multicenter, phase 2 study using a new drug named AKB9778 which inhibits VE-PTP and enhances Tie2. This has the potential to improve diabetic retinopathy. It is unique in that it does not require eye injections or lasers.It may help with other systemic diabetic issues.

PALADIN Study

About this Study

The specific objectives include the study of intraocular pressure (IOP) related data in patients who received ILUVIEN for the treatment of diabetic macular edema and how it relates to the patient's experiences following prior treatment with a course of corticosteroid which did not result in a clinically significant IOP elevation.

HAWK Study

About this Study

The purpose of this study is to compare RTH258 ophthalmic solution for intravitreal (IVT) injection at two dosage levels to aflibercept solution for IVT injection (2 mg) in subjects with untreated active choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) in the study eye.

Del Mar phase 2B DME Study

About this Study

A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical trial Designed to Evaluate the Safety and Exploratory Efficacy of LuminateĀ® (ALG-1001) as Compared to AvastinĀ® in the Treatment of Diabetic Macular Edema

CEDAR Study

About this Study

This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration.

PVD Study

About this Study

A Phase 2, Randomized, Double-masked, Placebo-controlled Multicenter Clinical Trial Designed to Evaluate the Safety and Efficacy of Luminate in Inducing PVD in Subjects with Non-Proliferative Diabetic Retinopathy.

Book Your Appointment Today

We have two convenient locations in Shirley and Commack of New York. Please feel free to call into our offices to learn more.

Contact Us